Latest Breaking News On - Neoantigen therapies - Page 1 : comparemela.com

12.06.2023 - LONDON, June 12, 2023 (GLOBE NEWSWIRE) - Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies to treat solid tumors, today announced that the Company will be taking .

United kingdomCity ofMelissa gardinerSukaina virjiAndrew craigMary jane elliottSergio quezadaConsilium strategic communicationsChief scientific officerClonal neoantigensAnnual immuno oncology summit europeSenior vice presidentData scienceNeoantigen therapiesArt neoantigen immunogenicityJane elliott